Handelsavisen
prelaunch
Companies Financials IPE.WA
IP
IPE.WA Warsaw Stock Exchange Investment Banking & Brokerage Services

Ipopema Securities SA

$6,70
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
3,03 %
Op margin
2,4 %
ROE
1,2 %
Net margin
2,2 %
Debt / equity
0,64
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Ipopema Securities SA provides investment banking and brokerage services in the financial sector, generating revenue primarily through trading, asset management, and advisory services.

Business. Ipopema Securities SA (IPE.WA) is a financial services firm operating in the investment banking and brokerage services industry. The company is headquartered in Poland and is primarily listed on the Warsaw Stock Exchange. It generates revenue through fee-based activities typical of the banking and investment services sector. Specific details regarding operating segments or geographic breakdowns are not available.

Classification92 %
SectorFinancials
Business sectorBanking & Investment Services
IndustryInvestment Banking & Brokerage Services
ActivityBanking & Investment Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
1,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning IPE.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to IPE.WA. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Ipopema Securities SA (IPE.WA) is a financial services firm operating in the investment banking and brokerage services industry. The company is headquartered in Poland and is primarily listed on the Warsaw Stock Exchange. It generates revenue through fee-based activities typical of the banking and investment services sector. Specific details regarding operating segments or geographic breakdowns are not available.

    Classification92 %
    SectorFinancials
    Business sectorBanking & Investment Services
    IndustryInvestment Banking & Brokerage Services
    ActivityBanking & Investment Services
    AI synthesis
    GENERATED

    Ipopema Securities SA has a liquidity profile that is currently rated as medium, with a debt-to-equity ratio of 0.64, indicating a moderate level of leverage. The company's free cash flow is relatively low at 1,095,000 PLN, and its capital expenditure is negative at -1,449,000 PLN, suggesting a reduction in capital spending or asset disposals. The company's return on equity is 1.2%, and its return on assets is 0.22%, both of which are below the typical performance benchmarks for the investment banking and brokerage services industry.

    In terms of profitability, Ipopema's operating income of 1,582,000 PLN and net income of 1,470,000 PLN reflect a modest level of earnings relative to its total assets of 675,004,000 PLN. The company's return on equity and return on assets are below the industry median, indicating that it is not generating returns as efficiently as its peers. This may be due to a combination of lower revenue growth and higher operating costs.

    Ipopema's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risk in the event of a downturn in its primary market or sector.

    The company's growth trajectory is not clearly defined in the available data, as there are no specific projections or outlooks provided for the current or next fiscal year. However, the modest net income and low free cash flow suggest that the company may be facing challenges in sustaining growth or expanding its operations.

    The risk assessment for Ipopema indicates a medium liquidity risk and a low dilution risk. The company's key financial flag is a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. There is no indication of significant dilution pressure in the near term, and the company's capital structure appears to be relatively stable.

    Recent events and filings for Ipopema are not detailed in the available data, but the company's financial performance and risk profile suggest that it may be underperforming relative to its peers in the investment banking and brokerage services industry. Investors should monitor the company's financial statements and any future disclosures for signs of improvement or deterioration in its business performance.

    Key takeaways
    • Ipopema has a moderate level of leverage with a debt-to-equity ratio of 0.64.
    • The company's return on equity and return on assets are below industry benchmarks.
    • Ipopema's revenue is concentrated in a single business segment, increasing its exposure to market risks.
    • The company's liquidity risk is rated as medium, with a negative net cash position after subtracting total debt.
    • There is no indication of significant dilution pressure in the near term.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Net income surged 162% year-over-year to PLN 23.9 million, demonstrating significant recent profitability acceleration.

    Free cash flow increased 514.7% to PLN 22.9 million, indicating strong cash generation capabilities in the latest period.

    Cash conversion ratio of 198.1% ranks as best-in-class within the investment banking and brokerage services cohort.

    Total assets grew 31.3% year-over-year to PLN 475.3 million, reflecting substantial balance sheet expansion.

    Revenue increased 15.5% year-over-year to PLN 296.9 million, showing consistent top-line growth momentum.

    BEAR CASE · 4

    Return on equity of 1.2% is significantly below the cohort median of 4.0%, indicating poor capital efficiency.

    The company faces a high credit risk level, posing potential threats to asset quality and future earnings.

    Debt-to-equity ratio of 0.64 is below the cohort median, suggesting higher leverage relative to peers.

    Return on assets of 0.22% is extremely low, highlighting minimal profitability generated from total assets.

    In focus — financials by report

    Valuation FY

    Market price
    $6,70
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $122.3M
    Net cash
    -$78.1M
    Current ratio
    Debt / equity
    0.6
    ROA
    0.2%
    ROE
    1.2%
    Cash conversion
    19810.0%
    CapEx / revenue
    -2.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin2,4 %Below median
    Net Margin2,2 %Bottom quartile
    ROE1,2 %Below median
    Capex / Rev-2,2 %Below median
    D/E0,64Below median
    Cash Conv198,10Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Ipopema Securities SA Market data — financials · 2026-05-28

    Ownership & reference

    Leadership

    • Jacek Wojciech JonakChairman of the Supervisory Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    IPE.WACanonical
    Warsaw Stock Exchange · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage